EPISODE · Mar 16, 2025 · 1H 10M
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
from The Long Run with Luke Timmerman · host Timmerman Report
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
What this episode covers
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
NOW PLAYING
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m